1-9 of 9
Recognizing the Liver: Understanding MASLD Risk in People with Metabolic Diseases
Medical Industry FeatureRecognizing the Liver: Understanding MASLD Risk in People with Metabolic Diseases
Nadege Gunn, MD, CPI, DABOM, FAASLD
Beyond the Scale: Reducing the Risk of Obesity Complications
Medical Industry FeatureBeyond the Scale: Reducing the Risk of Obesity Complications
Robert F. Kushner, MD
Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Medical Industry FeatureUncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Robert F. Kushner, MD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Medical Industry FeatureThe Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
LDL-C Management in Focus: A Clinical Dialogue Between Experts
Medical Industry FeatureLDL-C Management in Focus: A Clinical Dialogue Between Experts
Jaime Burkle, MD, FACC, FNLA
M. Chadi Alraies, MD, FACC, FSCAI
- advertisement
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
